Our partner in Kazakhstan
The EMCDDA's cooperates with Kazakhstan in the framework of the Central Asian Drug Action Programme (CADAP), which is currently in its sixth phase. CADAP 6 reflects the EU’s long-term engagement with Central Asian partners to help further strengthen their national policies in drug demand reduction.
News
Events
Publications
Publications related to this partner
Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.
This summary of the national drug situation in Kazakhstan was prepared within the framework of the Central Asia Drug Action Programme — Phase 5 (CADAP 5) in the Component DAMOS (Drug Epidemiology Database Collection and Development).
Document library
Contact information
No contact information currently available.